Related references
Note: Only part of the references are listed.DNA Damage-Binding Complex Recruits HDAC1 to Repress Bcl-2 Transcription in Human Ovarian Cancer Cells
Ran Zhao et al.
MOLECULAR CANCER RESEARCH (2014)
Platinum compounds in children with cancer: toxicity and clinical management
Antonio Ruggiero et al.
ANTI-CANCER DRUGS (2013)
Endoglin (CD105) Contributes to Platinum Resistance and Is A Target for Tumor-Specific Therapy in Epithelial Ovarian Cancer
Angela J. Ziebarth et al.
CLINICAL CANCER RESEARCH (2013)
FOX(M1) News-It Is Cancer
Marianna Halasi et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Cisplatin-induced nephrotoxicity and targets of nephroprotection: an update
Neife Aparecida Guinaim dos Santos et al.
ARCHIVES OF TOXICOLOGY (2012)
FOXM1 mediates Dox resistance in breast cancer by enhancing DNA repair
Yun-Yong Park et al.
CARCINOGENESIS (2012)
FoxM1 Inhibition Sensitizes Resistant Glioblastoma Cells to Temozolomide by Downregulating the Expression of DNA-Repair Gene Rad51
Nu Zhang et al.
CLINICAL CANCER RESEARCH (2012)
Exo1 plays a major role in DNA end resection in humans and influences double-strand break repair and damage signaling decisions
Nozomi Tomimatsu et al.
DNA REPAIR (2012)
DNA damage checkpoints in stem cells, ageing and cancer
Tobias Sperka et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
Molecular mechanisms of cisplatin resistance
L. Galluzzi et al.
ONCOGENE (2012)
Activating Transcription Factor 4 Confers a Multidrug Resistance Phenotype to Gastric Cancer Cells through Transactivation of SIRT1 Expression
Hongwu Zhu et al.
PLOS ONE (2012)
Suppression of FOXM1 Sensitizes Human Cancer Cells to Cell Death Induced by DNA-Damage
Marianna Halasi et al.
PLOS ONE (2012)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Multiple faces of FoxM1 transcription factor Lessons from transgenic mouse models
Tanya V. Kalin et al.
CELL CYCLE (2011)
Mismatch Repair Proteins MSH2, MLH1, and EXO1 Are Important for Class-Switch Recombination Events Occurring in B Cells That Lack Nonhomologous End Joining
Jennifer Eccleston et al.
JOURNAL OF IMMUNOLOGY (2011)
Integrated genomic analyses of ovarian carcinoma
D. Bell et al.
NATURE (2011)
Aberrant Activation of ERK/FOXM1 Signaling Cascade Triggers the Cell Migration/Invasion in Ovarian Cancer Cells
Gabriel T. M. Lok et al.
PLOS ONE (2011)
Retention of γH2AX foci as an indication of lethal DNA damage
Peggy L. Olive
RADIOTHERAPY AND ONCOLOGY (2011)
FoxM1 Mediates Resistance to Herceptin and Paclitaxel
Janai R. Carr et al.
CANCER RESEARCH (2010)
The Role of Oxidative Stress and Anti-Oxidant Treatment in Platinum-Induced Peripheral Neurotoxicity
V. A. Carozzi et al.
CURRENT CANCER DRUG TARGETS (2010)
FOXM1 Confers Acquired Cisplatin Resistance in Breast Cancer Cells
Jimmy M. -M. Kwok et al.
MOLECULAR CANCER RESEARCH (2010)
The DNA Damage Response: Making It Safe to Play with Knives
Alberto Ciccia et al.
MOLECULAR CELL (2010)
Phosphorylation of Exo1 modulates homologous recombination repair of DNA double-strand breaks
Emma Bolderson et al.
NUCLEIC ACIDS RESEARCH (2010)
Cancer Statistics, 2009
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2009)
Phase II Evaluation of Pemetrexed in the Treatment of Recurrent or Persistent Platinum-Resistant Ovarian or Primary Peritoneal Carcinoma: A Study of the Gynecologic Oncology Group
David S. Miller et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Sgs1 helicase and two nucleases Dna2 and Exo1 resect DNA double-strand break ends
Zhu Zhu et al.
CELL (2008)
The Forkhead Box M1 transcription factor contributes to the development and growth of mouse colorectal cancer
Yuichi Yoshida et al.
GASTROENTEROLOGY (2007)
Chk2 mediates stabilization of the FoxM1 transcription factor to stimulate expression of DNA repair genes
Yongjun Tan et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
The forkhead box m1 transcription factor stimulates the proliferation of tumor cells during development of lung cancer
IM Kim et al.
CANCER RESEARCH (2006)
Increased levels of the FoxM1 transcription factor accelerate development and progression of prostate carcinomas in both TRAMP and LADY transgenic mice
TV Kalin et al.
CANCER RESEARCH (2006)
Small interfering RNA-induced suppression of ERM enhances sensitivity of human cancer cells to cisplatin
IY Chang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
EX01-A multi-tasking eukaryotic nuclease
PT Tran et al.
DNA REPAIR (2004)
Identification and validation of commonly overexpressed genes in solid tumors by comparison of microarray data
C Pilarsky et al.
NEOPLASIA (2004)
Cisplatin: mode of cytotoxic action and molecular basis of resistance
ZH Siddik
ONCOGENE (2003)
Cell cycle checkpoint signaling through the ATM and ATR kinases
RT Abraham
GENES & DEVELOPMENT (2001)
Share Paper
